|
|
|
|
| LEADER |
04903nmm a2200349 u 4500 |
| 001 |
EB000674688 |
| 003 |
EBX01000000000000000527770 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9783642792786
|
| 100 |
1 |
|
|a Senn, Hans-Jörg
|e [editor]
|
| 245 |
0 |
0 |
|a Adjuvant Therapy of Breast Cancer V
|h Elektronische Ressource
|c edited by Hans-Jörg Senn, Richard D. Gelber, Aron Goldhirsch, Beat Thürlimann
|
| 250 |
|
|
|a 1st ed. 1996
|
| 260 |
|
|
|a Berlin, Heidelberg
|b Springer Berlin Heidelberg
|c 1996, 1996
|
| 300 |
|
|
|a XIV, 342 p
|b online resource
|
| 505 |
0 |
|
|a Intraductal Breast Carcinoma: Experiences from The Breast Center in Van Nuys, California -- Summary -- V. Surgery for Breast Cancer: Special Issues -- Surgical Treatment of Breast Cancer Relapse -- Primary and Secondary Breast Reconstruction with Special Emphasis on the Use of Prostheses -- The Primary Use of Chemotherapy for Operable Breast Cancer: Does Systemic Therapy Make Surgery Superfluous? -- Summary -- VI. Adjuvant Systemic Therapy -- The Role of Anthracyclines in Adjuvant Chemotherapy of Breast Cancer: A Critical Appraisal -- Adjuvant Systemic Therapy: The Issues of Timing and Sequence -- Current and Future Roles of Adjuvant Endocrine Therapy in the Management of Early Carcinoma of the Breast -- Future Developments in Adjuvant Systemic Therapy for High-Risk Breast Cancer -- Summary -- VII. Radiation Therapy as Part of PrimaryTreatment -- Radiation Therapy in the Primary Management of Early-Stage Breast Cancer --
|
| 505 |
0 |
|
|a Quality Assurance in Early Breast Cancer Treatment: Clinical Aspects of Postoperative, External, Whole Breast Irradiation -- How To Predict the Risk of Local Relapse in the Preserved Breast -- Summary -- VIII. Women’s Health Perception and Breast Cancer: Issues of Fertility, Hormone Substitution, and Cancer Prevention -- Reproductive Potential After Adjuvant Chemotherapy for Breast Cancer -- Sex Hormones and Breast Cancer: The Issue of Hormone Replacement -- The Women’s Health Initiative: Will It Resolve the Issues? -- The Women’s Health Initiative: The Road to Scientific Clarity? -- Design and Current Status of the NSABP Breast Cancer Prevention Trial -- Summary -- IX. International Consensus Conference on Primary Treatment of Breast Cancer -- Summary
|
| 505 |
0 |
|
|a The Control of Breast Cancer: A Look into the Future -- I. Epidemiology and Genetics of Breast Cancer -- Familial Breast Cancer -- The Food-Derived Heterocyclic Amines and Breast Cancer: A 1995 Perspective -- Menstrual Cycle Timing of Breast Cancer Resection -- Summary -- II. Biology of Breast Cancer -- Peptide Growth Factors and Breast Cancer Treatment: Recent Translational Research -- Single-Chain Fusion Toxins for the Treatment of Breast Cancer: Antitumor Activity of BR96 sFv-PE40 and Heregulin-PE40 -- Tamoxifen and Endometrial Cancer: From Experiment to Patient -- Summary -- III. Prognosis of Response and Tumor Markers -- Review of Known Prognostic Variables -- Prognostic Variables and Future Predictors of Behaviour and Response -- Serum (Circulating) Tumor Markers for Breast Cancer -- Summary -- IV. Screening for Breast Cancer and Treatment of Early Lesions (Ductal Carcinoma In Situ) -- A Critical Review of Screening for Breast Cancer -- Ductal Carcinoma In Situ --
|
| 653 |
|
|
|a Gynecology
|
| 653 |
|
|
|a Gynecology
|
| 653 |
|
|
|a Oncology
|
| 700 |
1 |
|
|a Gelber, Richard D.
|e [editor]
|
| 700 |
1 |
|
|a Goldhirsch, Aron
|e [editor]
|
| 700 |
1 |
|
|a Thürlimann, Beat
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a Recent Results in Cancer Research
|
| 028 |
5 |
0 |
|a 10.1007/978-3-642-79278-6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-642-79278-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.994
|
| 520 |
|
|
|a This volume provides an up-to-date survey of current laboratory and, mainly, clinical research on the diagnostic and treatment options in primary breast cancer. The chapters derive from the invited expert lectures presented at the 5th International Conference of Primary Breast Cancer held in St. Gallen, Switzerland, in March 1995. The papers cover relevant issues such as epidemiology and genetics as well as the biology of breast cancer, prognosis of response and tumor markers, screening and treatment of DCIS, surgery for early breast cancer, radiotherapy as part of primary management, adjuvant systemic cytotoxic and endocrine therapies, and, for the first time, women's health perceptions and breast cancer. As at previous conferences, this one also closed with an international consensus on the primary treatment of breast cancer, formulated by American, European, and Australian experts in various treatment modalities and biostatics. These 1995 treatment recommendations encompass pratical decisions outside of clinical trials and future research questions
|